 James Lavelle
Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Macrophages, Alveolar | 3 | 2020 | 389 | 0.360 |
Why?
| | Dexmedetomidine | 2 | 2014 | 43 | 0.210 |
Why?
| | Hypnotics and Sedatives | 2 | 2014 | 171 | 0.190 |
Why?
| | Hexosaminidases | 1 | 2019 | 18 | 0.160 |
Why?
| | Anti-Inflammatory Agents | 1 | 2020 | 478 | 0.130 |
Why?
| | Up-Regulation | 1 | 2019 | 837 | 0.120 |
Why?
| | Receptors, Antigen, T-Cell, gamma-delta | 1 | 2015 | 100 | 0.120 |
Why?
| | HIV Infections | 2 | 2020 | 2719 | 0.120 |
Why?
| | Lorazepam | 1 | 2014 | 26 | 0.110 |
Why?
| | Midazolam | 1 | 2013 | 51 | 0.110 |
Why?
| | T-Lymphocyte Subsets | 1 | 2015 | 412 | 0.100 |
Why?
| | Conscious Sedation | 1 | 2013 | 84 | 0.100 |
Why?
| | Acute Lung Injury | 1 | 2015 | 278 | 0.100 |
Why?
| | Mental Recall | 1 | 2013 | 191 | 0.100 |
Why?
| | Anticonvulsants | 1 | 2014 | 209 | 0.100 |
Why?
| | Lipopolysaccharides | 1 | 2015 | 871 | 0.100 |
Why?
| | Inflammation | 2 | 2020 | 2723 | 0.090 |
Why?
| | Substance Withdrawal Syndrome | 1 | 2014 | 174 | 0.090 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2019 | 981 | 0.090 |
Why?
| | Ethanol | 1 | 2014 | 587 | 0.080 |
Why?
| | Smokers | 2 | 2020 | 138 | 0.080 |
Why?
| | Critical Care | 1 | 2013 | 551 | 0.080 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2020 | 642 | 0.060 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2004 | 123 | 0.050 |
Why?
| | Catheterization | 1 | 2003 | 175 | 0.050 |
Why?
| | Catheterization, Central Venous | 1 | 2003 | 103 | 0.050 |
Why?
| | Arrhythmias, Cardiac | 1 | 2004 | 315 | 0.050 |
Why?
| | Cross Infection | 1 | 2003 | 216 | 0.050 |
Why?
| | Bacteremia | 1 | 2003 | 197 | 0.050 |
Why?
| | Stress, Physiological | 1 | 2004 | 413 | 0.040 |
Why?
| | Immunophenotyping | 1 | 2020 | 311 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2014 | 1871 | 0.040 |
Why?
| | Intensive Care Units | 2 | 2014 | 735 | 0.040 |
Why?
| | Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 2015 | 4 | 0.030 |
Why?
| | Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 2015 | 8 | 0.030 |
Why?
| | Capillary Leak Syndrome | 1 | 2015 | 12 | 0.030 |
Why?
| | Middle Aged | 4 | 2020 | 31075 | 0.030 |
Why?
| | Coculture Techniques | 1 | 2015 | 226 | 0.030 |
Why?
| | Interleukin-4 | 1 | 2015 | 212 | 0.030 |
Why?
| | Adult | 4 | 2020 | 35471 | 0.030 |
Why?
| | Stress Disorders, Traumatic, Acute | 1 | 2013 | 6 | 0.030 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 421 | 0.030 |
Why?
| | Infusions, Intravenous | 1 | 2014 | 398 | 0.030 |
Why?
| | Smoking | 1 | 2020 | 1499 | 0.030 |
Why?
| | Cytokines | 1 | 2020 | 2011 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2015 | 1303 | 0.020 |
Why?
| | Drug Therapy, Combination | 1 | 2014 | 1037 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2015 | 1195 | 0.020 |
Why?
| | Male | 5 | 2020 | 63498 | 0.020 |
Why?
| | Dose-Response Relationship, Drug | 1 | 2014 | 2003 | 0.020 |
Why?
| | Pilot Projects | 1 | 2013 | 1584 | 0.020 |
Why?
| | Female | 4 | 2020 | 68607 | 0.020 |
Why?
| | Lung | 1 | 2020 | 3916 | 0.020 |
Why?
| | Biomarkers | 1 | 2019 | 3968 | 0.020 |
Why?
| | Anxiety | 1 | 2013 | 959 | 0.020 |
Why?
| | Humans | 5 | 2020 | 129219 | 0.020 |
Why?
| | Mice, Inbred C57BL | 1 | 2015 | 5408 | 0.010 |
Why?
| | Depression | 1 | 2013 | 1302 | 0.010 |
Why?
| | Physical Stimulation | 1 | 2004 | 74 | 0.010 |
Why?
| | Ventricular Fibrillation | 1 | 2004 | 57 | 0.010 |
Why?
| | Electrophysiology | 1 | 2004 | 210 | 0.010 |
Why?
| | Equipment Safety | 1 | 2003 | 38 | 0.010 |
Why?
| | Equipment Contamination | 1 | 2003 | 56 | 0.010 |
Why?
| | Rabbits | 1 | 2004 | 778 | 0.010 |
Why?
| | Confidence Intervals | 1 | 2003 | 317 | 0.010 |
Why?
| | Myocardial Ischemia | 1 | 2004 | 250 | 0.010 |
Why?
| | Probability | 1 | 2003 | 306 | 0.010 |
Why?
| | Young Adult | 1 | 2019 | 12403 | 0.010 |
Why?
| | In Vitro Techniques | 1 | 2004 | 1083 | 0.010 |
Why?
| | Prospective Studies | 1 | 2014 | 7103 | 0.010 |
Why?
| | Equipment Design | 1 | 2003 | 513 | 0.010 |
Why?
| | Acute Disease | 1 | 2004 | 977 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2013 | 5394 | 0.010 |
Why?
| | Biomechanical Phenomena | 1 | 2004 | 763 | 0.010 |
Why?
| | Action Potentials | 1 | 2004 | 485 | 0.010 |
Why?
| | Ventricular Function, Left | 1 | 2004 | 526 | 0.010 |
Why?
| | Odds Ratio | 1 | 2003 | 1023 | 0.010 |
Why?
| | Heart Ventricles | 1 | 2004 | 779 | 0.010 |
Why?
| | Animals | 2 | 2015 | 35219 | 0.010 |
Why?
| | Mice | 1 | 2015 | 16861 | 0.010 |
Why?
| | Blood Pressure | 1 | 2004 | 1727 | 0.010 |
Why?
| | Incidence | 1 | 2003 | 2638 | 0.010 |
Why?
| | Aged | 1 | 2013 | 22030 | 0.010 |
Why?
| | Risk Assessment | 1 | 2003 | 3234 | 0.010 |
Why?
|
|
Lavelle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|